| Absorption |
| Blood-Brain Barrier | BBB- | 0.9707 |
| Human Intestinal Absorption | HIA+ | 0.8224 |
| Caco-2 Permeability | Caco2+ | 0.6302 |
| P-glycoprotein Substrate | Substrate | 0.7841 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.8316 |
| Non-inhibitor | 0.7581 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9376 |
| Distribution |
| Subcellular localization | Mitochondria | 0.7786 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7968 |
| CYP450 2D6 Substrate | Non-substrate | 0.8771 |
| CYP450 3A4 Substrate | Substrate | 0.6961 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9046 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9071 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9231 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9025 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8734 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.5745 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9956 |
| Non-inhibitor | 0.6021 |
| AMES Toxicity | Non AMES toxic | 0.8911 |
| Carcinogens | Non-carcinogens | 0.9182 |
| Fish Toxicity | High FHMT | 0.9938 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9846 |
| Honey Bee Toxicity | Low HBT | 0.6779 |
| Biodegradation | Not ready biodegradable | 1.0000 |
| Acute Oral Toxicity | III | 0.5284 |
| Carcinogenicity (Three-class) | Non-required | 0.6484 |